InVivo Therapeutics Holdings Corp. logo
InVivo Therapeutics Holdings Corp. NVIV
$ 0.31 -37.48%

Quarterly report 2023-Q3
added 11-08-2023

report update icon

InVivo Therapeutics Holdings Corp. Balance Sheet 2011-2024 | NVIV

Annual Balance Sheet InVivo Therapeutics Holdings Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-15.4 M -17.7 M -18.7 M -5.29 M -16.6 M -12.1 M -20.2 M -18.5 M -11.5 M -12 M -11.2 M -4.23 M

Long Term Debt

553 K 949 K 693 K - - 400 K 852 K 1.28 M 1.6 M 1.94 M 1.58 M 83.8 K

Long Term Debt Current

396 K 361 K 327 K 294 K - - - - - - - -

Total Non Current Liabilities

- - 752 K 1.08 M 61 K 823 K 987 K 1.55 M 1.6 M 1.94 M 1.58 M 122 K

Total Current Liabilities

2.47 M 2.61 M 1.97 M 2.66 M 2.2 M 3.11 M 4.85 M 3.31 M 9.18 M 2.27 M 16.8 M 36.7 M

Total Liabilities

3.08 M 3.66 M 2.72 M 3.74 M 2.27 M 3.94 M 5.84 M 4.86 M 10.8 M 4.21 M 18.4 M 36.9 M

Deferred Revenue

- - - - - - - - - - - -

Retained Earnings

-249 M -238 M -228 M -219 M -207 M -184 M -157 M -134 M -100 M -81.9 M -43.2 M -47.8 M

Total Assets

18.8 M 21.8 M 21.9 M 9.32 M 18.4 M 14 M 34.8 M 21.8 M 16.7 M 17.1 M 16.1 M 5.7 M

Cash and Cash Equivalents

16.4 M 19 M 19.5 M 6.6 M 16.7 M 12.9 M 21.5 M 14.9 M 13.5 M 14 M 12.8 M 4.36 M

Book Value

15.7 M 18.1 M 19.2 M 5.58 M 16.1 M 10.1 M 28.9 M 16.9 M 5.92 M 12.9 M -2.31 M -31.2 M

Total Shareholders Equity

15.7 M 18.1 M 19.2 M 5.58 M 16.1 M 10.1 M 28.9 M 16.9 M 5.92 M 12.9 M -2.31 M -31.2 M

All numbers in USD currency

Quarterly Balance Sheet InVivo Therapeutics Holdings Corp.

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 280 K 417 K 553 K 656 K 755 K 853 K 949 K 530 K 629 K 605 K 693 K 693 K 693 K 693 K 1.02 M 1.02 M 1.02 M 1.02 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

666 K 1.76 M 2.18 M 3.08 M 3.26 M 3.26 M 3.02 M 3.66 M 2.63 M 2.5 M 2.16 M 2.72 M 2.72 M 2.72 M 2.72 M 3.74 M 3.74 M 3.74 M 3.74 M 2.27 M 2.27 M 2.27 M 2.27 M 3.94 M 3.94 M 3.94 M 3.94 M 5.84 M 5.84 M 5.84 M 5.84 M 4.86 M 4.86 M 4.86 M 4.86 M 10.8 M 10.8 M 10.8 M 10.8 M 4.21 M 4.21 M 4.21 M 4.21 M 18.4 M 18.4 M 18.4 M 18.4 M 36.9 M 36.9 M 36.9 M 36.9 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-256 M -253 M -251 M -249 M -246 M -244 M -241 M -238 M -235 M -233 M -230 M -228 M -228 M -228 M -228 M -219 M -219 M -219 M -219 M -207 M -207 M -207 M -207 M -184 M -184 M -184 M -184 M -157 M -157 M -157 M -157 M -134 M -134 M -134 M -134 M -100 M -100 M -100 M -100 M -81.9 M - - - - - - - - - - -

Total Assets

9.58 M 13.3 M 15.7 M 18.8 M 13.4 M 16.1 M 18.5 M 21.8 M 23.6 M 25.8 M 27.7 M 21.9 M 21.9 M 21.9 M 21.9 M 9.32 M 9.32 M 9.32 M 9.32 M 18.4 M 18.4 M 18.4 M 18.4 M 14 M 14 M 14 M 14 M 34.8 M 34.8 M 34.8 M 34.8 M 21.8 M 21.8 M 21.8 M 21.8 M 16.7 M 16.7 M 16.7 M 16.7 M 17.1 M 17.1 M 17.1 M 17.1 M 16.1 M 16.1 M 16.1 M 16.1 M 5.7 M 5.7 M 5.7 M 5.7 M

Cash and Cash Equivalents

8.58 M 10.7 M 13.1 M 16.4 M 10.7 M 13.2 M 15.3 M 19 M 21.3 M 23.2 M 24.8 M 19.6 M 19.5 M 19.5 M 19.5 M 6.6 M 6.6 M 6.6 M 6.6 M 16.7 M 16.7 M 16.7 M 16.7 M 12.9 M 12.9 M 12.9 M 12.9 M 21.5 M 21.5 M 21.5 M 21.5 M 14.9 M 20.2 M 20.2 M 20.2 M 13.5 M 13.5 M 13.5 M 13.5 M 14 M 14 M 14 M 14 M 12.8 M 12.8 M 12.8 M 12.8 M 4.36 M 4.36 M 4.36 M 4.36 M

Book Value

8.92 M 11.6 M 13.5 M 15.7 M 10.1 M 12.8 M 15.5 M 18.1 M 20.9 M 23.3 M 25.5 M 19.2 M 19.2 M 19.2 M 19.2 M 5.58 M 5.58 M 5.58 M 5.58 M 16.1 M 16.1 M 16.1 M 16.1 M 10.1 M 10.1 M 10.1 M 10.1 M 28.9 M 28.9 M 28.9 M 28.9 M 16.9 M 16.9 M 16.9 M 16.9 M 5.92 M 5.92 M 5.92 M 5.92 M 12.9 M 12.9 M 12.9 M 12.9 M -2.31 M -2.31 M -2.31 M -2.31 M -31.2 M -31.2 M -31.2 M -31.2 M

Total Shareholders Equity

8.92 M 11.6 M 13.5 M 15.7 M 10.1 M 12.8 M 15.5 M 18.1 M 20.9 M 23.3 M 25.5 M 19.2 M 19.2 M 19.2 M 19.2 M 5.58 M 5.58 M 5.58 M 5.58 M 16.1 M 16.1 M 16.1 M 16.1 M 10.1 M 10.1 M 10.1 M 10.1 M 28.9 M 28.9 M 28.9 M 28.9 M 16.9 M 16.9 M 16.9 M 16.9 M 5.92 M 5.92 M 5.92 M 5.92 M 12.9 M 12.9 M 12.9 M 12.9 M -2.31 M -2.31 M -2.31 M -2.31 M -31.2 M -31.2 M -31.2 M -31.2 M

All numbers in USD currency